<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tian X</submitter><funding>National Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>823</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9512921</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(9)</volume><pubmed_abstract>Liver ischemia/reperfusion (I/R) injury is a major clinical concern of liver transplantation, which accounts for organ rejection and liver dysfunction. The adaptor protein p66Shc acts as a crucial redox enzyme and is implicated in liver I/R. Elevated p66Shc expression is associated with hepatocellular apoptosis in liver I/R, but the molecular mechanisms of p66Shc responsible for its aberrant expression and function remain unknown. In the present study, hepatocyte-specific p66Shc-knockdown mice exhibited clear inhibition in hepatocellular apoptosis and oxidative stress under liver I/R, while hepatocyte-specific p66Shc overexpression mice displayed the deteriorative impairment. Mechanistically, p66Shc-triggered mitochondrial fission and apoptosis in liver I/R by mediating ROS-driven Drp1 act</pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>USP15 regulates p66Shc stability associated with Drp1 activation in liver ischemia/reperfusion.</pubmed_title><pmcid>PMC9512921</pmcid><funding_grant_id>81721091</funding_grant_id><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Tian X</pubmed_authors><pubmed_authors>Zheng S</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Lu Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>USP15 regulates p66Shc stability associated with Drp1 activation in liver ischemia/reperfusion.</name><description>Liver ischemia/reperfusion (I/R) injury is a major clinical concern of liver transplantation, which accounts for organ rejection and liver dysfunction. The adaptor protein p66Shc acts as a crucial redox enzyme and is implicated in liver I/R. Elevated p66Shc expression is associated with hepatocellular apoptosis in liver I/R, but the molecular mechanisms of p66Shc responsible for its aberrant expression and function remain unknown. In the present study, hepatocyte-specific p66Shc-knockdown mice exhibited clear inhibition in hepatocellular apoptosis and oxidative stress under liver I/R, while hepatocyte-specific p66Shc overexpression mice displayed the deteriorative impairment. Mechanistically, p66Shc-triggered mitochondrial fission and apoptosis in liver I/R by mediating ROS-driven Drp1 act</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-22T06:24:48.316Z</modification><creation>2025-04-05T21:41:47.722Z</creation></dates><accession>S-EPMC9512921</accession><cross_references><pubmed>36163170</pubmed><doi>10.1038/s41419-022-05277-8</doi></cross_references></HashMap>